DXCM

Dexcom Inc

Jun 12 • 04:00PM ET

75.37

+0.12 0.16 %

Healthcare • Medical Devices • USA • Large • NASD

Peers: ABT MDT SYK BSX RMD EW BAX BDX ISRG ZBH

| Held by: VTI QQQ VOO VO IVV SPY VUG XLV IWP RSP

Index	NDX, S&P 500	P/E	32.24	EPS (ttm)	2.34	Insider Own	1.76%	Shs Outstand	385.90M	Perf Week	3.44%
Market Cap	29.08B	Forward P/E	24.42	EPS next Y	3.09	Insider Trans	-0.64%	Shs Float	379.08M	Perf Month	28.68%
Enterprise Value	28.05B	PEG	1.17	EPS next Q	0.61	Inst Own	97.51%	Short Float	4.59%	Perf Quarter	17.33%
Income	930.40M	P/S	6.04	EPS this Y	23.92%	Inst Trans	0.66%	Short Ratio	3.20	Perf Half Y	11.56%
Sales	4.82B	P/B	9.84	EPS next Y	19.20%	ROA	13.90%	Short Interest	17.39M	Perf YTD	13.56%
Book/sh	7.66	P/C	12.04	EPS next 5Y	20.80%	ROE	35.62%	52W High	89.98 -16.24%	Perf Year	-9.03%
Cash/sh	6.26	P/FCF	20.35	EPS past 3/5Y	37.83% 10.55%	ROIC	21.53%	52W Low	54.11 39.29%	Perf 3Y	-40.61%
Dividend Est.	-	EV/EBITDA	21.71	Sales past 3/5Y	17.01% 19.33%	Gross Margin	62.64%	Volatility	4.54% 4.25%	Perf 5Y	-24.67%
Dividend TTM	-	EV/Sales	5.82	EPS Y/Y TTM	76.15%	Oper. Margin	21.45%	ATR (14)	2.86	Perf 10Y	319.25%
Dividend Ex-Date	-	Quick Ratio	1.64	Sales Y/Y TTM	16.15%	Profit Margin	19.31%	RSI (14)	62.85	Recom	1.39
Dividend Gr. 3/5Y	- -	Current Ratio	1.95	EPS Q/Q	92.21%	SMA20	4.38%	Beta	1.42	Target Price	85.33
Payout	0.00%	Debt/Eq	0.47	Sales Q/Q	15.05%	SMA50	14.43%	Rel Volume	0.88	Prev Close	75.25
Employees	11100	LT Debt/Eq	0.46	Earnings	Apr 30 AMC	SMA200	11.55%	Avg Volume	5.43M	Price	75.37
IPO	Apr 14, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.27% 1.47%	Trades		Volume	4,760,637	Change	0.16%

Date	Action	Analyst	Rating Change	Price Target Change
May-12-26	Initiated	The Benchmark Company	Buy	$77
Mar-24-26	Upgrade	Evercore ISI	In-line → Outperform	$90
Jan-12-26	Downgrade	Barclays	Equal Weight → Underweight	$71
Dec-02-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$75
Nov-25-25	Initiated	Evercore ISI	In-line	$68
Oct-21-25	Resumed	Stifel	Buy	$85
Sep-08-25	Downgrade	Oppenheimer	Outperform → Perform
Aug-21-25	Initiated	Argus	Buy	$100
Jun-16-25	Initiated	Truist	Buy	$102
May-30-25	Initiated	Goldman	Buy	$104
Apr-10-25	Initiated	Mizuho	Outperform	$85
Feb-03-25	Upgrade	Redburn Atlantic	Neutral → Buy	$85 → $115
Jan-16-25	Upgrade	Robert W. Baird	Neutral → Outperform	$86 → $104
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142

Show Previous Ratings

Jun-09-26 04:30PM	Insulet Corp. stock outperforms competitors on strong trading day (MarketWatch)
Jun-08-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +5.16%
Jun-06-26 02:45PM	Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin (Business Wire)
Jun-05-26 06:25AM	Dexcom buys Nutrisense; Insulet rolls out patch pump update (MedTech Dive)
Jun-04-26 09:00AM	Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026 (Business Wire)
09:44AM	Loading…
May-27-26 09:44AM	Signos raises $20M, expands Dexcom partnership for weight loss (Quartz)
09:44AM	Glucose-tracking startup Signos is raising $20M and expanding its Dexcom partnership (Quartz)
May-26-26 09:30AM	Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users (Business Wire)
May-22-26 04:36PM	QuantumCore Announces Changes to Board of Directors (TMX Newsfile)
11:12AM	Harnessing medtech market alliances, URA sets IPO plans in motion (Medical Device Network)
May-21-26 01:00AM	Live Longer and Better. Does Medicine's New Obsession Really Work? (Barrons.com)
May-20-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +6.71%
May-18-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +5.61%
07:31AM	Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany (Business Wire)
May-15-26 04:30PM	DexCom Inc. stock outperforms competitors on strong trading day (MarketWatch) +6.59%
12:50PM	Loading…
12:50PM	Dexcom Just Made A Lofty Promise To Its Investors - Why Analysts Are Bullish (Investor's Business Daily)
07:48AM	Dexcom to add 2 board directors with activist investor Elliott (MedTech Dive)
May-14-26 04:02PM	Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day (Business Wire)
May-13-26 04:30PM	Insulet Corp. stock underperforms Wednesday when compared to competitors (MarketWatch)
May-12-26 09:56AM	Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls (The Fly)
08:56AM	Dexcom gets a new Buy rating at Benchmark on expected margin expansion (Investing.com)
May-05-26 08:30AM	Dexcom to Host Investor Day on May 14, 2026 (Business Wire)
May-01-26 08:30AM	DexCom, Inc. Q1 2026 Earnings Call Summary (Moby)
07:25AM	Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook (Medical Device Network)
03:18AM	DexCom Inc (DXCM) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ... (GuruFocus.com)
Apr-30-26 04:09PM	DexCom: Q1 Earnings Snapshot (Associated Press)
04:02PM	Dexcom Reports First Quarter 2026 Financial Results (Business Wire)
Apr-29-26 10:30AM	Why Medtech Giants Are Quietly Paying Up for AI Diagnostics (PR Newswire)
Apr-21-26 11:59AM	Study Supports GlucoTracks Blood Glucose Monitoring Implant (Exec Edge)
Apr-09-26 06:50PM	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
08:30AM	Loading…
Apr-02-26 08:30AM	Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time (Business Wire)
Apr-01-26 08:30AM	American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA (TMX Newsfile)
Mar-31-26 03:09PM	MiniMed initiated with Buy rating by Bank of America on pipeline-driven growth outlook (Proactive)
Mar-11-26 05:26AM	DexCom price target raised to $84 from $77 at Citi (TipRanks)
02:00AM	Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 (Business Wire)
Mar-09-26 09:45AM	Here's Why DexCom (DXCM) is a Strong Growth Stock (Zacks)
Mar-05-26 08:41AM	Is DexCom Stock Underperforming the Nasdaq? (Barchart)
Feb-26-26 04:15PM	Dexcom Appoints Rick Osterloh to Board of Directors (Business Wire)
08:03AM	Aristotle Growth Equity Fund Bets on DexCom (DXCM) Due to Its Expanding CGM Market Leadership (Insider Monkey)
Feb-25-26 08:00PM	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
08:30AM	Dexcom Announces Upcoming Conference Presentation (Business Wire)
Feb-24-26 09:29PM	Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat (Insider Monkey)
11:33AM	AdvaMed names Jake Leach as chair of diabetes sector (MedTech Dive)
06:25AM	Medtronics MiniMed prices IPO at up to $784M (MedTech Dive)
Feb-23-26 03:40PM	DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership (Insider Monkey)
Feb-20-26 09:45AM	Why DexCom (DXCM) is a Top Growth Stock for the Long-Term (Zacks)
07:15AM	SENS Eversense 365 Integrated With twiist Gains Full Availability (Zacks)
05:00AM	Senseonics launches automated insulin dosing system with 1-year CGM (MedTech Dive)
Feb-19-26 12:38AM	The 5 Most Interesting Analyst Questions From DexCom's Q4 Earnings Call (StockStory)
Feb-17-26 01:11PM	Medtronic Posts Better-Than-Expected Earnings. Heres Why the Stock Is Falling. (Barrons.com)
Feb-15-26 06:52AM	DexCom Inc. (DXCM) Reports Strong Performance While Maintaining Forward Outlook (Insider Monkey)
Feb-13-26 04:36PM	Analyst Report: DexCom, Inc. (Morningstar Research) +7.59%
04:34PM	Stocks Settle Slightly Higher as Bond Yields Fall (Barchart)
01:48PM	Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday? (Benzinga)
12:35PM	DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth (Zacks)
12:10PM	Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations (Medical Device Network)
11:31AM	Why Is DexCom (DXCM) Stock Rocketing Higher Today (StockStory)
08:55AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
08:30AM	DexCom, Inc. Q4 2025 Earnings Call Summary (Moby)
12:35AM	DXCM Q4 Deep Dive: New Product Launches and International Strategy Drive Outlook (StockStory)
12:04AM	DexCom Inc (DXCM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
Feb-12-26 06:19PM	DexCom Q4 Earnings Call Highlights (MarketBeat)
05:50PM	DexCom Reports Better-Than-Expected Q4 Results: Details (Benzinga)
05:15PM	DexCom (DXCM) Q4 Earnings and Revenues Top Estimates (Zacks)
04:26PM	DexCom: Q4 Earnings Snapshot (Associated Press Finance)
04:11PM	DexCom (NASDAQ:DXCM) Exceeds Q4 CY2025 Expectations (StockStory)
04:03PM	Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results (Business Wire)
Feb-11-26 11:00AM	Medical Device Stocks to Report Earnings on Feb. 12: BAX, WST & DXCM (Zacks)
09:31AM	What Are Wall Street Analysts' Target Price for DexCom Stock? (Barchart)
Feb-10-26 10:12PM	Earnings To Watch: DexCom (DXCM) Reports Q4 Results Tomorrow (StockStory)
01:30PM	Baxter to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
11:22AM	Will DXCM Deliver Q4 Earnings Beat on G7 Stabilization, Volume Growth? (Zacks)
10:00AM	Glaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
09:15AM	Countdown to DexCom (DXCM) Q4 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
Feb-09-26 11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)
10:24AM	WST Q4 Earnings Preview: Can HVP Momentum Continue to Drive Margins? (Zacks)
Feb-06-26 07:42AM	Wearables future in healthcare likely to hinge on actionable insights (Medical Device Network)
Feb-05-26 12:33PM	DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features (Zacks)
10:00AM	DexCom (DXCM) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Feb-04-26 01:55PM	Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings (Zacks)
09:45AM	DexCom (DXCM) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:30AM	Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management (Business Wire)
Feb-03-26 11:31AM	GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy? (Zacks)
09:28AM	Should You Buy, Sell, or Hold McKesson Before Q3 Earnings? (Zacks)
Jan-30-26 02:31PM	Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive (Insider Monkey)
05:00AM	Senseonics wins CE mark for one-year CGM (MedTech Dive)
Jan-29-26 05:00PM	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
12:51PM	Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery? (Zacks)
08:33AM	Can Specialty and International Momentum Support Cencora's Q1 Results? (Zacks)
Jan-28-26 11:33PM	3 Former Stock Picks Are Quietly Flashing Buy Signals Again (Barrons.com)
09:50AM	Here's Why DexCom (DXCM) is a Strong Momentum Stock (Zacks)
08:24AM	SYK's Q4 Results Likely to Reflect Procedure Growth and Capital Demand (Zacks)
Jan-27-26 12:59PM	HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes (Zacks)
08:38AM	Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments (Insider Monkey)
08:30AM	Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time. (Business Wire)
08:04AM	Could 2026 Be Dexcom's 'Get Right' Year? New CEO Jake Leach Says Yes. (Investor's Business Daily)
Jan-23-26 07:30PM	Analyst Report: DexCom, Inc. (Morningstar Research)
08:48AM	Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock? (Zacks)
Jan-22-26 08:59PM	Analyst Report: DexCom, Inc. (Morningstar Research)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Executive Chairman of the BoardMr. Kevin Ronald Sayer

PresidentMr. Jacob Steven Leach

Executive VPMr. Jereme M. Sylvain CPA

Executive VP & Chief Legal OfficerMr. Michael Jon Brown J.D.

Executive VP & Chief Human Resources OfficerMs. Sadie M. Stern

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Coleman Jon	EVP, Chief Commercial Officer	Jun 04 '26	Sale	74.13	4,911	364,052	95,450	Jun 05 04:17 PM
Coleman Jon	EVP, Chief Commercial Officer	Jun 03 '26	Sale	73.00	4,912	358,576	100,361	Jun 05 04:17 PM
JON C COLEMAN	Officer	Jun 04 '26	Proposed Sale	74.13	4,911	364,052		Jun 04 04:10 PM
JON C COLEMAN	Officer	Jun 03 '26	Proposed Sale	73.00	4,912	358,576		Jun 03 04:03 PM
SAYER KEVIN R	Executive Chair	May 21 '26	Sale	72.00	26,759	1,926,648	382,482	May 26 04:18 PM
KEVIN R SAYER	Officer	May 21 '26	Proposed Sale	72.00	26,759	1,926,648		May 21 05:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	May 15 '26	Sale	59.91	1,700	101,847	109,504	May 19 04:34 PM
MICHAEL BROWN	Officer	May 15 '26	Proposed Sale	59.91	1,700	101,847		May 15 04:05 PM
Heller Bridgette P	Director	May 12 '26	Sale	60.01	1,012	60,730	25,007	May 14 04:39 PM
Heller Bridgette P	Director	May 12 '26	Proposed Sale	60.01	1,012	60,730		May 12 09:47 AM
Brown Michael Jon	EVP, Chief Legal Officer	Apr 15 '26	Sale	63.04	1,700	107,168	111,204	Apr 16 07:27 PM
MICHAEL BROWN	Officer	Apr 15 '26	Proposed Sale	63.04	1,700	107,168		Apr 15 04:06 PM
Brown Michael Jon	EVP, Chief Legal Officer	Mar 16 '26	Sale	64.85	1,700	110,245	112,904	Mar 18 04:07 PM
MICHAEL BROWN	Officer	Mar 16 '26	Proposed Sale	64.85	1,700	110,245		Mar 16 04:02 PM
Heller Bridgette P	Director	Feb 12 '26	Sale	68.01	1,012	68,826	26,019	Feb 17 04:36 PM
Heller Bridgette P	Director	Feb 12 '26	Proposed Sale	68.01	1,012	68,826		Feb 12 09:51 AM
Collins Richard Alexander	Director	Nov 14 '25	Sale	59.05	2,906	171,599	35,088	Nov 17 05:52 PM
Collins Richard Alexander	Director	Nov 14 '25	Proposed Sale	59.05	2,906	171,599		Nov 14 09:50 AM
Heller Bridgette P	Director	Nov 12 '25	Sale	58.07	1,012	58,767	27,031	Nov 12 05:14 PM
Heller Bridgette P	Director	Nov 12 '25	Proposed Sale	58.07	1,012	58,767		Nov 12 10:52 AM
Leach Jacob Steven	President & COO	Nov 10 '25	Buy	55.04	18,200	1,001,702	331,697	Nov 10 07:13 PM
Collins Richard Alexander	Director	Nov 10 '25	Sale	55.17	3,948	217,811	37,994	Nov 10 07:12 PM
Collins Richard Alexander	Director	Nov 10 '25	Proposed Sale	55.17	3,948	217,811		Nov 10 09:52 AM
Malady Kyle	Director	Sep 05 '25	Sale	80.86	667	53,934	22,667	Sep 09 04:18 PM
Stern Sadie	EVP, Chief HR Officer	Sep 04 '25	Sale	80.00	1,466	117,280	105,223	Sep 08 04:06 PM
Malady Kyle	Director	Sep 05 '25	Proposed Sale	80.86	667	53,934		Sep 05 11:08 AM
SADIE STERN	Officer	Sep 04 '25	Proposed Sale	80.00	1,466	117,280		Sep 04 04:29 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Sep 02 '25	Sale	74.17	4,824	357,796	118,657	Sep 04 04:13 PM
JEREME SYLVAIN	Officer	Sep 02 '25	Proposed Sale	74.17	4,824	357,796		Sep 02 04:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	Aug 15 '25	Sale	80.29	500	40,145	94,102	Aug 18 05:56 PM
FOLETTA MARK G	Director	Aug 15 '25	Sale	81.06	2,750	222,903	51,121	Aug 18 05:53 PM
MICHAEL BROWN	Officer	Aug 15 '25	Proposed Sale	80.29	500	40,145		Aug 15 04:57 PM
FOLETTA MARK G	Director	Aug 15 '25	Proposed Sale	80.29	2,750	220,798		Aug 15 04:04 PM
Stern Sadie	EVP, Chief HR Officer	Jul 28 '25	Sale	88.99	1,466	130,459	106,689	Jul 29 04:18 PM
SADIE STERN	Officer	Jul 28 '25	Proposed Sale	88.99	1,466	130,459		Jul 28 04:29 PM
FOLETTA MARK G	Director	Jul 15 '25	Sale	85.17	2,750	234,217	53,871	Jul 17 04:08 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jul 15 '25	Sale	86.03	500	43,015	94,602	Jul 17 04:03 PM
MICHAEL BROWN	Officer	Jul 15 '25	Proposed Sale	86.03	500	43,015		Jul 15 04:11 PM
FOLETTA MARK G	Director	Jul 15 '25	Proposed Sale	86.03	2,750	236,582		Jul 15 04:02 PM
Stern Sadie	EVP, Chief HR Officer	Jun 26 '25	Sale	85.06	1,466	124,698	108,155	Jun 30 06:47 PM
SADIE STERN	Officer	Jun 26 '25	Proposed Sale	85.06	1,466	124,698		Jun 26 04:04 PM
FOLETTA MARK G	Director	Jun 16 '25	Sale	83.13	2,750	228,605	56,621	Jun 18 04:31 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jun 16 '25	Sale	82.80	500	41,400	95,102	Jun 18 04:31 PM
AUGUSTINOS NICHOLAS	Director	Jun 16 '25	Sale	82.80	3,672	304,042	33,411	Jun 17 05:33 PM
MICHAEL BROWN	Officer	Jun 16 '25	Proposed Sale	82.80	500	41,400		Jun 16 04:12 PM
FOLETTA MARK G	Director	Jun 16 '25	Proposed Sale	82.80	2,750	227,700		Jun 16 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your Finviz experience